Human target validation of phosphoinositide 3-kinase (PI3K)β: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor
Version of Record online: 1 OCT 2012
© 2012 International Society on Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis
Volume 10, Issue 10, pages 2127–2136, October 2012
How to Cite
NYLANDER, S., KULL, B., BJÖRKMAN, J. A., ULVINGE, J. C., OAKES, N., EMANUELSSON, B. M., ANDERSSON, M., SKÄRBY, T., INGHARDT, T., FJELLSTRÖM, O. and GUSTAFSSON, D. (2012), Human target validation of phosphoinositide 3-kinase (PI3K)β: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor. Journal of Thrombosis and Haemostasis, 10: 2127–2136. doi: 10.1111/j.1538-7836.2012.04898.x
- Issue online: 1 OCT 2012
- Version of Record online: 1 OCT 2012
- Accepted manuscript online: 20 AUG 2012 10:32AM EST
- Received 16 March 2012, accepted 26 July 2012
Data S1. Materials and methods.
|JTH_4898_sm_SupplementS1.doc||127K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.